Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2011 Jul 7:7:11.
doi: 10.1186/1746-160X-7-11.

The effects of Bleomycin A5 on infantile maxillofacial haemangioma

Quan-feng Luo  1 , Fu-yun Zhao
Affiliations
Comparative Study

The effects of Bleomycin A5 on infantile maxillofacial haemangioma

Quan-feng Luo et al. Head Face Med. .

Abstract

Objective: To examine the effects of bleomycin A5 on infantile maxillofacial haemangiomas.

Methods: Bleomycin A5 was given by multiple intralesinoal injections and the dosage was given according to the age of the patient and size of the lesion. Parts of patients were accompanied by prednisone treatment (2-5 mg/kg, po, QOD.

Results: All the haemangiomas involutes completely after treated with bloemycin A5 with better recovery of skin color and less scar forming in small haemangiomas.

Conclusion: Infantile haemangioma could be effectively treated with bleomycin A5 without serious side effects.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Age of first consultation.
Figure 2
Figure 2
Distribution of hemangioma size.
Figure 3
Figure 3
This boy presented at 40 days of age with a hemangioma in the left parotid area. Bleomycin A5 was given once every 4 weeks for a total of 7 treatments.
Figure 4
Figure 4
The hemangioma had completely involuted one year later. The overall response was Scale II.
Figure 5
Figure 5
This girl had a hemangioma at the center of her face that involved the nose, right eyelid, and bilateral medial canthi.
Figure 6
Figure 6
The hemangioma involuted one year and five months after bleomycin treatment. The overall response was Scale II.
Figure 7
Figure 7
A large hemangioma was present on the left face, involving the eyelid, nose, and upper lip. Bleomycin A5 was given once a month for 7 months. Four months later, treatment was resumed again. The total treatment period was 2 years and 4 months.
Figure 8
Figure 8
Three years later, the hemangioma had completely involuted, with few scars, the overall was Scale I.
See this image and copyright information in PMC

References

    1. Pienaar Conrad, Graham Roger, Geldenhuys Stuart. et al.Intralesional Bleomycin for the Treatment of Hemangiomas. Plast Reconstr Surg. 2006;117:221–226. doi: 10.1097/01.prs.0000194906.61805.b0. - DOI - PubMed
    1. Omidvari S, Nezakatgoo N, Ahmadloo N. et al.Role of intralesional bleomycin in the treatment of complicated hemangiomas: prospective clinical study. Dermatol-Surg. 2005;31(5):499–501. - PubMed
    1. Muir T, Kirsten M, Fourie P. et al.Intralesional bleomycin injection (IBI) treatment for haemangiomasand congenital vascular malformations. Pediatr Surg Int. 2004;19:766–773. doi: 10.1007/s00383-003-1058-6. - DOI - PubMed
    1. Ming Li-June. Structure and Function of Metalloantibiotics. Medicinal Research Reviews. 2003;23(6):697–762. doi: 10.1002/med.10052. - DOI - PubMed
    1. Marek J. Ostrowski An Assessment of the Long-Term Results of Controlling the Reaccumulation of Malignant Effusions Using lntracavity Bleomycin. Cancer. 1986;57:721–727. doi: 10.1002/1097-0142(19860215)57:4<721::AID-CNCR2820570407>3.0.CO;2-5. - DOI - PubMed

Publication types

MeSH terms